Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | CA7 | P43166 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | GBA1 | P04062 | 2/20 | 0.47 |
| ▸ | UGCG | Q16739 | 2/20 | 0.47 |
| ▸ | GBA2 | Q9HCG7 | 2/20 | 0.47 |
| ▸ | MMP3 | P08254 | 3/20 | 0.44 |
| ▸ | MMP8 | P22894 | 3/20 | 0.44 |
| ▸ | MMP9 | P14780 | 2/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.44 |
| ▸ | MMP1 | P03956 | 2/20 | 0.44 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.43 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.43 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.43 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL517512 | 1.00 | CA1 (0.50) | CA1L3MBTL1TDP1CA2CA7 | |
| SCHEMBL8608254 | 1.00 | CA1 (0.50) | CA1L3MBTL1TDP1CA2CA7 | |
| SCHEMBL25238062 | 1.00 | CA1 (0.50) | CA1L3MBTL1TDP1CA2CA7 | |
| SCHEMBL19032486 | 1.00 | CA1 (0.50) | CA1L3MBTL1TDP1CA2CA7 | |
| SCHEMBL3429104 | 0.92 | CSNK1E (0.49) | CA1L3MBTL1TDP1CA2CA7 | |
| SCHEMBL22749478 | 0.92 | CSNK1E (0.49) | CA1L3MBTL1TDP1CA2CA7 | |
| SCHEMBL6026038 | 0.92 | CSNK1E (0.49) | CA1L3MBTL1TDP1CA2CA7 | |
| SCHEMBL31362251 | 0.92 | CSNK1E (0.49) | CA1L3MBTL1TDP1CA2CA7 | |
| SCHEMBL15153556 | 0.92 | CSNK1E (0.49) | CA1L3MBTL1TDP1CA2CA7 | |
| SCHEMBL31362254 | 0.92 | CSNK1E (0.49) | CA1L3MBTL1TDP1CA2CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260102348-A1 | COMPOUND OR SALT THEREOF AND LIPID PARTICLES | FUJIFILM CORPORATION (JP) | 2026-04-16 | — | — | US | disclosed |
| US-12508226-B2 | Lipid composition | FUJIFILM CORPORATION (JP) | 2025-12-30 | — | — | US | disclosed |
| US-12370143-B2 | Compound or salt thereof and lipid particles | FUJIFILM CORPORATION (JP) | 2025-07-29 | — | — | US | disclosed |
| EP-4328309-B1 | LIPID COMPOSITION | FUJIFILM CORP (JP) | 2025-07-02 | — | — | EP | disclosed |
| US-12285525-B2 | Compound or salt thereof and lipid particles | FUJIFILM CORPORATION (JP) | 2025-04-29 | — | — | US | disclosed |
| CN-116172975-B | Lipid particle, nucleic acid drug comprising same, and composition for nucleic acid delivery | 富士胶片株式会社 | 2025-03-28 | — | — | CN | disclosed |
| CN-114728016-B | Lipid composition | 富士胶片株式会社 | 2024-10-29 | — | — | CN | disclosed |
| US-20240315970-A1 | COMPOUND OR SALT THEREOF AND LIPID PARTICLES | FUJIFILM CORPORATION (JP) | 2024-09-26 | — | — | US | disclosed |
| CN-113924128-B | Lipid composition | 富士胶片株式会社 | 2024-09-06 | — | — | CN | disclosed |
| EP-4328309-A2 | LIPID COMPOSITION | FUJIFILM Corporation (JP) | 2024-02-28 | — | — | EP | disclosed |
| CN-116172975-A | Lipid particle, nucleic acid drug comprising same, and composition for nucleic acid delivery | 富士胶片株式会社 | 2023-05-30 | — | — | CN | disclosed |
| EP-4059505-A1 | LIPID COMPOSITION | FUJIFILM Corporation (JP) | 2022-09-21 | — | — | EP | disclosed |
| US-20220273817-A1 | LIPID COMPOSITION | FUJIFILM CORPORATION (JP) | 2022-09-01 | — | — | US | disclosed |
| CN-114828830-A | Pharmaceutical composition and treatment agent | 富士胶片株式会社 | 2022-07-29 | — | — | CN | disclosed |
| CN-114728016-A | Lipid composition | 富士胶片株式会社 | 2022-07-08 | — | — | CN | disclosed |
| EP-3981435-A1 | LIPID COMPOSITION | FUJIFILM Corporation (JP) | 2022-04-13 | — | — | EP | disclosed |
| US-20220096381-A1 | LIPID COMPOSITION | FUJIFILM CORPORATION (JP) | 2022-03-31 | — | — | US | disclosed |
| EP-3805198-A1 | COMPOUND, SALT THEREOF AND LIPID PARTICLES | FUJIFILM Corporation (JP) | 2021-04-14 | — | — | EP | disclosed |
| US-20210085604-A1 | COMPOUND OR SALT THEREOF AND LIPID PARTICLES | FUJIFILM CORPORATION (JP) | 2021-03-25 | — | — | US | disclosed |
| US-20210085604-A1 | COMPOUND OR SALT THEREOF AND LIPID PARTICLES | FUJIFILM CORPORATION (JP) | 2021-03-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12370143-B2 | Compound or salt thereof and lipid particles | NR1H3, NR1H2, LDLR | CA1 1978/4885L3MBTL1 1766/4885TDP1 3943/4885 |
| US-12285525-B2 | Compound or salt thereof and lipid particles | NR1H3, NR1H2, LDLR | CA1 1978/4885L3MBTL1 1766/4885TDP1 3943/4885 |
| US-20240315970-A1 | COMPOUND OR SALT THEREOF AND LIPID PARTICLES | NR1H3, NR1H2, LDLR | CA1 1978/4885L3MBTL1 1766/4885TDP1 3943/4885 |
| US-20260102348-A1 | COMPOUND OR SALT THEREOF AND LIPID PARTICLES | LDLR, NR1H3, NR1H2 | CA1 1711/4885L3MBTL1 628/4885TDP1 3096/4885 |
| US-20210085604-A1 | COMPOUND OR SALT THEREOF AND LIPID PARTICLES | NR1H3, NR1H2, LDLR | CA1 2014/4885L3MBTL1 1762/4885TDP1 3999/4885 |
| US-20220273817-A1 | LIPID COMPOSITION | NR1H3, NR1H2, NR1H4 | CA1 1647/4885L3MBTL1 1451/4885TDP1 2730/4885 |
| US-20220096381-A1 | LIPID COMPOSITION | NR1H3, NR1H4, NR1H2 | CA1 1432/4885L3MBTL1 961/4885TDP1 3539/4885 |
| US-12508226-B2 | Lipid composition | APOB, NAF1, SLC27A1 | CA1 1120/4885L3MBTL1 460/4885TDP1 2967/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.